fda compounding peptides bpc-157 warning letter issued 25 letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Partnership for Safe Medicines urges
Description
Vukojevi et al
Using a contaminated or compromised diluent is like putting contaminated fuel into a high-performance engine
Combination Research: BPC-157 is frequently co-administered with TB-500 in preclinical protocols
Switch from cyanocobalamin to methylcobalamin (or vice versa), drop the dose, or change the delivery route
